Abstract:Objective The aim of this study was to explore possible pharmacokinetic factors and develop a population pharmacokinetic model for remifentanil in adult patients.Methods Eleven healthy patients,undergoing elective major abdominal surgery,aged 25 to 86 years,received random-ly remifentanil 0.3μg·kg-1 ·min-1 (group R3),or 0.6μg·kg-1 ·min-1 (group R6).Frequent ar-terial blood samples were drawn according to predetermined time and assayed for remifentanil concen-tration.Nonlinear mixed-effects modeling (NONMEM)was used to evaluate the time courses of the measured concentrations.The covariates include age,bodyweight (WT),gender,lean body mass (LBM),body mass index (BMI)and body surface area (BSA).Results The pharmacokinetic data of remifentanil were well described using a three-compartment linear model with first-order elimination from the central compartment.Forward analysis showed that age,height and body mass index (BMI) does not affect the pharmacokinetic parameters,which are contrast with body weight,lean body mass (LBM),body surface area (BSA)and gender;further analysis demonstrated only a significant effect of body weight on remifentanil systemic clearance (CL)and volume of the central compartment (V). For typical 60 years patients,PK parameters were:V1 =7.64 L,V2 =4.81 L,V3 =4.34 L,CL1 =2.74 L/min,CL2 = 0.738 L/min,CL3 = 0.0905 L/min.Conclusion The pharmacokinetics of remifentanil is consistent with its rapid elimination by blood and tissue esterase in Chinese patients. The systemic clearance and volume of distribution of central compartment increases with body weight in the population and the range of covariates studied,which suggests that a patient with greater body weight needs a greater initial dose and maintenance infusion rate higher to obtain a stable plasma con-centrations and clinical effects.

Study of Pharmacokinetics of Remifenatil in Human Body

Determination of Remifentanil in Human Blood by HPLC/MS/MS

Determination Concentration of Remifentanil in Surgery Human Blood by HPLC/MS/MS and Study on Its Pharmacokinetics

SIMULTANEOUS LC-MS/MS QUANTIFICATION METHOD FOR REMOGLIFLOZIN ETABONATE AND METFORMIN IN PLASMA SAMPLES: APPLICATION OF KINETIC STUDY IN RABBITS

Comparison of the pharmacokinetics of remifentanil in Chinese elder and adult patients

HPLC-MS/MS method for the determination of sufentanil in human plasma

A liquid chromatography-tandem mass spectrometry method for the quantitation of imidafenacin in human plasma: application to a clinical pharmacokinetic study

Pharmacokinetics of Remifentanil in Patients Undergoing General Anesthesia

Simultaneous determination of amoxicillin and ambroxol in human plasma by LC-MS/MS: validation and application to pharmacokinetic study

Pharmacokinetics of Remifentanil in Chinese Patients Undergoing Elective Surgery

Population pharmacokinetics of remifentanil in adult patients undergoing elective major abdominal sur-gery

Determination of Ketamine, Fluoroketamine, Norketamine, and 2-Norfluoro-ketamine in Urine using Ultra-performance Liquid Chromatography-tandem Mass Spectrometry

On-site Quantitation of Morphine in Urine by Fast Derivatization and Miniature Mass Spectrometry Analysis

Simultaneous Determination of Levo-tetrahydropalmatine and Naltrexone in Rat Plasma by LC-MS/MS and its Application in a Pharmacokinetic Study

Simultaneous Quantitation of Paracetamol, Caffeine, Pseudoephedrine, Chlorpheniramine and Cloperastine in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry

Rapid and sensitive liquid chromatography tandem mass spectrometry method for the quantification of ambroxol in human plasma.

Simultaneous determination of tramadol and its active metabolite 3-O-demethyltra-madol in human plasma by LC-MS/MS and its application to bioequivalence

Study on Urinary Metabonmics Using Rapid Resolution Liquid Chromatography Tandem Mass Spectrometry

SIMULTANEOUS DETERMINATION OF PARACETAMOL/TRAMADOL AND ITS METABOLITE IN HUMAN PLASMA BY REVERSED-PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Simultaneous Determination of Paracetamol and Amantadine in Human Plasma and Bioequivalence of Its Preparations in Healthy Volunteers by LC-MS

Simultaneous Quantification Of 38 Psychotropic Drugs And Relevant Metabolites In Blood Using Lc-Ms-Ms